Anebulo Pharmaceuticals, Inc.
ANEB
$1.39
$0.129.45%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 158.01% | 125.73% | -83.52% | -72.49% | -63.66% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 136.03% | 113.34% | -40.66% | -2.11% | -16.47% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 157.09% | 125.86% | -78.31% | -69.94% | -62.79% |
|
|||||
Total Current Assets | 157.09% | 125.86% | -78.31% | -69.94% | -62.79% |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -67.91% | -34.89% | -- | -- | -- |
Total Assets | 133.65% | 111.19% | -72.72% | -65.10% | -58.46% |
|
|||||
Total Accounts Payable | 11.09% | 0.25% | -55.45% | -70.74% | -32.58% |
Total Accrued Expenses | -81.05% | -19.51% | 110.56% | -80.50% | -32.04% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | -45.96% | -13.30% | -20.57% | -75.62% | -32.24% |
|
|||||
Total Current Liabilities | -45.96% | -13.30% | -20.57% | -75.62% | -32.24% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | -45.96% | -13.30% | -20.57% | -75.62% | -32.24% |
|
|||||
Common Stock & APIC | 23.42% | 23.43% | 2.19% | 2.08% | 2.06% |
Retained Earnings | -12.01% | -12.29% | -13.27% | -14.34% | -17.09% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 170.04% | 130.64% | -77.21% | -64.04% | -61.48% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 170.04% | 130.64% | -77.21% | -64.04% | -61.48% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 170.04% | 130.64% | -77.21% | -64.04% | -61.48% |
|